论文信息 - Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study - 字舞流文

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

E. Van Cutsem | R. Kelley | C. Verslype | W. Su | N. Vogelzang | F. Braiteh | A. Spira | A. Cohn | H. Burris | P. Foster | Yihua Lee | Y. Lee | E. Cutsem | W. Su | Tsai‐Sheng Yang